Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long‐term follow‐up of a multi‐center prospective study

Impact of bone marrow fibrosis grade in post‐polycythemia vera and post‐essential thrombocythemia myelofibrosis: A study of the MYSEC group

“…At SMF diagnosis, we did not find any correlation between BMF grade and age, gender, time to progression from PV/ET, spleen and liver size, presence of constitutional symptoms and marrow blast percentage (Table S1). No relationship was noticed with abnormal karyotype (stratified as previously reported) 6 with data available in about 50% of the cohort (Table S1). Looking at genotype, BMF grading was not differently distributed among the three driver mutations as well as in "triple negative" cases (Table S1).…”